OC&C advises Azimut during Cieffe Derma transaction

Friday 28 January 2022 | News

We are pleased to congratulate Azimut on its successful acquisition of a majority stake in Cieffe Derma, a leading Italian company in the formulation and distribution of dermo-cosmetic products and supplements in the pharmaceutical industry. The business operates through a wide network of medical and scientific representatives. Their range includes products for the treatment of numerous areas therapeutic in dermatology and in gynaecology with widely recognised brands including Oilfree, Macrocea and Dermaffine.

Following the transaction Azimut will become the controlling shareholder working alongside the founder Salvatore Frontera.

For more details on our experience, please contact our team.
 

We use cookies to give you the best possible experience on our website. By continuing to browse this site, you give consent for cookies to be used. For more details please read our Cookie policy.